S. Sakaguchi et al. / Journal of Organometallic Chemistry 695 (2010) 195–200
197
J = 16.3 Hz, 1H), 5.29 (d, J = 16.3 Hz, 1H), 4.83 (t, J = 5.7 Hz, 1H),
2.4.9. 1-[2-((S)-1-hydroxy-4-methyl-2-pentanylamino)-2-oxoethyl]-
3-butylimidazolium chloride (15)
4.13 (s, 3H), 3.85–3.78 (m, 1H), 3.35–3.31 (m, 2H), 1.65–1.55 (m,
1H), 1.38–1.26 (m, 2H), 0.86 (d, J = 6.4 Hz, 3H), 0.79 (d, J = 6.4 Hz,
3H); 13C NMR: d 164.1, 143.6, 131.8, 126.4, 113.6, 113.5, 63.5,
49.6, 48.8, 39.8, 33.3, 24.2, 23.5, 21.8. Anal. Calc. for
C16H24ClN3O2ꢀ2H2O: C, 53.11; H, 7.80; N, 11.61. Found: C, 53.09;
1H NMR (DMSO): d 9.29 (s, 1H), 8.50 (d, J = 8.5 Hz, 1H), 7.80 (s,
1H), 7.73 (s, 1H), 5.02 (d, J = 16.3 Hz, 1H), 4.98 (d, J = 16.3 Hz, 1H),
4.83 (t, J = 12.0 Hz, 1H), 4.21 (t, J = = 14.1 Hz, 2H), 3.80–3.72 (m,
1H), 3.33–3.29 (m, 2H), 1.79–1.72 (m, 2H), 1.61–1.55 (m, 1H),
1.32–1.21 (m, 4H), 0.90–0.80 (m, 9H); 13C NMR: d 164.3, 137.2,
123.7, 121.6, 63.3, 50.6, 49.5, 48.4, 31.3, 24.1, 23.1, 21.9, 18.6,
13.2. Anal. Calc. for C15H28ClN3O2ꢀH2O: C, 53.64; H, 9.00; N,
H, 7.28; N, 11.62%. ½a D25
¼ ꢂ10:0 (c = 1.0 in CH3OH). M.p. 180.0–
ꢁ
180.4 °C.
2.4.3. 1-[2-((S)-1-hydroxy-3,3-dimethyl-2-butanylamino)-2-
oxoethyl]-3-methylbenzimidazolium chloride (9)
12.51. Found: C, 53.95; H, 8.66; N, 12.64%. ½a D25
¼ þ5:9 (c = 1.0 in
ꢁ
CH3OH). M.p. 52.8–53.1 °C.
1H NMR (DMSO): d 9.89 (s, 1H), 8.63 (d, J = 9.0 Hz, 1H), 8.03–
8.00 (m, 2H), 7.67–7.65 (m, 2H), 5.53 (d, J = 16.3 Hz, 1H), 5.43 (d,
J = 16.3 Hz, 1H), 4.70 (t, J = 5.7 Hz, 1H), 4.13 (s, 3H), 3.60–3.57 (m,
2H), 3.43–3.40 (m, 1H), 0.86 (s, 9H); 13C NMR: d 164.8, 143.6,
131.4, 131.3, 126.5, 126.3, 113.5, 113.4, 60.2, 59.8, 48.6, 33.5,
33.2, 26.8. Anal. Calc. for C16H24ClN3O2ꢀ2.5H2O: C, 51.82; H, 7.88;
2.4.10. 1-[2-((S)-1-hydroxy-4-methyl-2-pentanylamino)-2-oxoethyl]-
3-benzylimidazolium chloride (16)
1H NMR (DMSO): d 9.34 (s, 1H), 8.37 (br, 1H), 7.81 (s, 1H), 7.72
(s, 1H), 7.42–7.38 (m, 5H), 5.50 (s, 2H), 5.04 (d, J = 16.3 Hz, 1H),
4.99 (d, J = 16.3 Hz, 1H), 4.77 (t, J = 5.9 Hz, 1H), 3.81–3.73 (m,
1H), 3.34–3.26 (m, 2H), 1.62–1.55 (m, 1H), 1.32–1.28 (m, 2H),
0.86 (d, J = 6.6 Hz, 3H), 0.82 (d, J = 6.6 Hz, 3H); 13C NMR: d 164.3,
137.4, 134.9, 129.0, 128.7, 128.2, 124.1, 121.8, 63.4, 51.8, 50.7,
49.6, 39.8, 24.1, 23.2, 21.9. Anal. Calc. for C18H26ClN3O2: C, 61.44;
H, 7.45; N, 11.94. Found: C, 61.26; H, 7.25; N, 11.92%.
N, 11.33. Found: C, 51.50; H, 7.59; N, 11.32%. ½a D25
¼ þ15:9
ꢁ
(c = 1.0 in CH3OH). M.p. 53.4–53.8 °C.
2.4.4. 1-[2-((S)-1-hydroxy-2-phenyl-2-ethanylamino)-2-oxoethyl]-3-
methylbenzimidazolium chloride (10)
1H NMR (CD3OD): d 7.95–7.93 (m, 1H), 7.86–7.84 (m, 1H), 7.73–
7.65 (m, 2H), 7.37–7.31 (m, 4H), 7.28–7.24 (m, 1H), 5.42 (d,
J = 16.6 Hz, 1H), 5.38 (d, J = 16.6 Hz, 1H), 5.03–5.00 (m, 1H), 4.14
(s, 3H), 3.83–3.74 (m, 2H); 13C NMR: d 166.4, 140.5, 133.3, 133.1,
129.7, 128.7, 128.3, 128.2, 128.0, 114.3, 114.2, 66.0, 57.7, 49.6,
33.8. Anal. Calc. for C18H20ClN3O2ꢀH2O: C, 59.42; H, 6.09; N,
½
a 2D5
ꢁ
¼ ꢂ17:0 (c = 1.0 in CH3OH). M.p. 178.0–178.3 °C.
2.5. General procedure for preparation of 3a and 7a
A suspension of azolium salt 3 or 7 (0.5 mmol) and silver(I)
oxide (0.25 mmol) in CH2Cl2 (35 mL) was stirred for 1.5 h at reflux-
ing temperature. After the reaction, a white precipitate was
formed, which was filtered with suction. The resulting white solid
was dissolved in DMSO-d6, and then the NMR measurement was
performed.
11.55. Found: C, 59.39; H, 5.88; N, 11.57%. ½a D25
¼ þ105:7 (c = 1.0
ꢁ
in CH3OH). M.p. 162.5–163.0 °C.
2.4.5. 1-[2-((S)-1-hydroxy-3-methyl-2-butanylamino)-2-oxoethyl]-3-
methylimidazolium chloride (11)
1H NMR (CD3OD): d 8.96 (s, 1H), 7.60 (d, J = 1.8 Hz, 1H), 7.59 (d,
J = 1.8 Hz, 1H), 5.08 (d, J = 15.8 Hz, 1H), 5.03 (d, J = 15.8 Hz, 1H),
3.95 (s, 3H), 3.75–3.55 (m, 3H), 1.92–1.83 (m, 1H), 0.94 (m, 6H);
13C NMR: d 167.0, 139.3, 125.0, 124.4, 63.0, 58.8, 51.9, 36.6, 30.2,
2.5.1. NHC–Ag complex 3a
1H NMR (DMSO): d 7.96 (br, 1H), 7.38 (d, J = 1.7 Hz, 1H), 7.36 (d,
J = 1.7 Hz, 1H), 4.91 (d, J = 15.7 Hz, 1H), 4.80 (d, J = 15.7 Hz, 1H),
4.63 (br, 1H), 3.80 (s, 3H), 3.61–3.51 (m, 1H), 3.42–3.32 (m, 2H),
1.86–1.72 (m, 1H), 0.81 (d, J = 7.2 Hz, 3H), 0.78 (d, J = 7.2 Hz, 3H);
13C NMR: d 181.6, 166.5, 123.3, 122.4, 61.1, 55.9, 53.0, 38.0, 28.2,
19.6, 18.1.
19.9, 18.8. ½a 2D5
¼ ꢂ10:9 (c = 1.0 in CH3OH).
ꢁ
2.4.6. 1-[2-((S)-1-hydroxy-3-methyl-2-butanylamino)-2-oxoethyl]-3-
butylimidazolium chloride (12)
1H NMR (CD3OD): d 9.04 (s, 1H), 7.67 (t, J =3.3 Hz, 1H), 7.61 (t,
J = 3.3 Hz, 1H), 5.10 (d, J= 16.5 Hz, 1H), 5.04 (d, J = 16.5 Hz, 1H),
4.25 (t, J = 14.5 Hz, 2H), 3.73–3.52 (m, 3H), 1.94–1.83 (m, 3H),
1.42–1.34 (m, 2H), 1.01–0.92 (m, 9H); 13C NMR: d 167.0, 125.0,
123.1, 63.0, 58.8, 51.9, 50.7, 33.0, 30.2, 20.4, 19.7, 18.8, 13.7.
2.5.2. NHC–Ag complex 7a
1H NMR (DMSO): d 8.20 (br, 1H), 7.78–7.76 (m, 1H), 7.66–7.63
(m, 1H), 7.47–7.43 (m, 2H), 5.23 (d, J = 15.9 Hz, 1H), 5.14 (d,
J = 15.4 Hz, 1H), 4.67 (br, 1H), 4.05 (s, 3H), 3.60–3.56 (m, 1H),
3.44–3.43 (m, 2H), 1.87–1.82 (m, 1H), 0.86–0.84 (m, 6H); 13C
NMR: d 166.0, 133.8, 133.7, 123.9, 123.7, 112.0, 111.9, 61.2, 56.1,
50.9, 35.6, 28.2, 19.7, 18.2, the carbene 13C NMR resonance was
not observed.
½
a 2D5
ꢁ
¼ ꢂ11:0 (c = 1.0 in CH3OH).
2.4.7. 1-[2-((S)-1-hydroxy-3-methyl-2-butanylamino)-2-oxoethyl]-3-
benzylimidazolium chloride (13)
1H NMR (CD3OD): d 9.10 (s, 1H), 7.63–7.61 (m, 2H), 7.44–7.40
(m, 5H), 5.45 (s, 2H), 5.09 (d, J = 16.3 Hz, 1H), 5.04 (d, J = 16.3 Hz,
1H), 3.75–3.53 (m, 3H), 1.91–1.82 (m, 1H), 0.95 (d, J = 6.9 Hz,
3H), 0.93 (d, J = 6.9 Hz, 3H); 13C NMR: d 166.9, 138.8, 135.1,
130.4, 130.3, 129.6, 125.4, 123.2, 63.0, 58.8, 54.1, 52.1, 30.2, 19.9,
2.6. General procedure for preparation of 8b, 10b, 12b and 13b
A suspension of azolium compound (0.12 mmol) and silver(I)
oxide (0.07 mmol) in CH2Cl2 (5 mL) was stirred for 2 h in the dark
at refluxing temperature. The reaction mixture was concentrated
under reduced pressure to give a white solid. [PdCl2(CH3CN)2]
(0.1 mmol) was added to a suspension of the resulting silver com-
plex in CH3CN (5 mL) in the dark at room temperature. Then, the
resulting suspension was stirred for 2 h and filtered through a plug
of glass fiber filter paper. The filtrate was evaporated to dryness in
vacuo, and the Pd complexes were crystallized from ethyl acetate
or methanol. The yield of 8b, 10b, 12b and 13b were 79%, 52%,
11% and 17%, respectively. These complexes are very stable under
air and could be stored for at least 1 month at room temperature.
18.8. ½a 2D5
¼ ꢂ13:8 (c = 1.0 in CH3OH). M.p. 156.1–156.5 °C.
ꢁ
2.4.8. 1-[2-((S)-1-hydroxy-4-methyl-2-pentanylamino)-2-oxoethyl]-
3-methylimidazolium chloride (14)
1H NMR (DMSO):d 9.14 (s, 1H), 8.38 (d, J = 8.2 Hz, 1H), 7.69 (s,
1H), 7.68 (s, 1H), 4.99 (d, J = 16.5 Hz, 1H), 4.94 (d, J = 16.5 Hz,
1H), 4.81 (t, J = 11.9 Hz, 1H), 3.87 (s, 3H), 3.80–3.73 (m, 1H),
3.32–3.28 (m, 2H), 1.63–1.51 (m, 1H), 1.32–1.27 (m, 2H), 0.86 (d,
J = 6.6 Hz, 3H), 0.82 (d, J = 6.3 Hz, 3H); 13C NMR: d 164.3, 137.7,
123.7, 122.9, 63.4, 50.6, 49.5, 39.9, 35.8, 24.2, 23.2, 21.9.
½
a 2D5
ꢁ
¼ ꢂ12:0 (c = 1.0 in CH3OH). M.p. 176.8–177.1 °C.